Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins.
Pathways to Parkinson's disease: a spotlight on 14-3-3 proteins.
复制标题
DOI:
10.1038/s41531-021-00230-6
复制
发表时间:
2021-09-21
期刊:
影响因子:
--
通讯作者:
Civiero L
中科院分区:
文献类型:
--
作者:
Giusto E;Yacoubian TA;Greggio E;Civiero L
14-3-3s represent a family of highly conserved 30 kDa acidic proteins. 14-3-3s recognize and bind specific phospho-sequences on client partners and operate as molecular hubs to regulate their activity, localization, folding, degradation, and protein–protein interactions. 14-3-3s are also associated with the pathogenesis of several diseases, among which Parkinson’s disease (PD). 14-3-3s are found within Lewy bodies (LBs) in PD patients, and their neuroprotective effects have been demonstrated in several animal models of PD. Notably, 14-3-3s interact with some of the major proteins known to be involved in the pathogenesis of PD. Here we first provide a detailed overview of the molecular composition and structural features of 14-3-3s, laying significant emphasis on their peculiar target-binding mechanisms. We then briefly describe the implication of 14-3-3s in the central nervous system and focus on their interaction with LRRK2, α-Synuclein, and Parkin, three of the major players in PD onset and progression. We finally discuss how different types of small molecules may interfere with 14-3-3s interactome, thus representing a valid strategy in the future of drug discovery.
登录
查看更多内容
影响因子:
56.9
作者:
Choudhary, Chunaram;Kumar, Chanchal;Mann, Matthias
通讯作者:
Mann, Matthias
影响因子:
8.6
作者:
Appel-Cresswell, Silke;Vilarino-Guell, Carles;Farrer, Matthew J.
通讯作者:
Farrer, Matthew J.
影响因子:
4.8
作者:
Civiero L;Cogo S;Kiekens A;Morganti C;Tessari I;Lobbestael E;Baekelandt V;Taymans JM;Chartier-Harlin MC;Franchin C;Arrigoni G;Lewis PA;Piccoli G;Bubacco L;Cookson MR;Pinton P;Greggio E
通讯作者:
Greggio E
影响因子:
168.9
作者:
Chartier-Harlin, MC;Kachergus, J;Destée, A
通讯作者:
Destée, A
影响因子:
3.5
作者:
Biosa, Alice;Trancikova, Alzbeta;Moore, Darren J.
通讯作者:
Moore, Darren J.